Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

Mary Ann Huang1, Jorge A Marrero

  • 1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Gastroenterology·2026
Same author

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Gastro hep advances·2025
Same author

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal of hepatology·2025
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2025
Same author

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2025
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Hepatocellular carcinoma research is growing, but survival rates remain stagnant. Hepatitis B genotype B shows promise for better outcomes in specific patients, alongside recommended screening and new imaging techniques.

Area of Science:

  • Hepatology
  • Oncology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) research publications have surged recently.
  • Despite increased research, 1-year survival for HCC has seen minimal improvement over two decades, with no change in overall survival.

Purpose of the Study:

  • To review current trends and findings in hepatocellular carcinoma research.
  • To highlight prognostic factors, screening recommendations, diagnostic advancements, and therapeutic options for HCC.

Main Methods:

  • Literature review of recent publications on hepatocellular carcinoma.
  • Analysis of survival data, prognostic indicators (Hepatitis B genotypes), and screening guidelines.
  • Evaluation of gene expression studies using microarray technology.

Related Experiment Videos

  • Assessment of advanced imaging techniques (MRI, Doppler ultrasound) and treatment modalities (transplantation, resection).

    • Main Results:

    • Hepatitis B genotype B is associated with improved response and survival in HCC patients with chronic Hepatitis B infection.
    • Screening with ultrasound and alpha-fetoprotein every 6 months is recommended for Child-Turcotte-Pugh class A or B cirrhosis patients.
    • Microarray studies have identified genes involved in hepatic carcinogenesis.
    • Dynamic gadolinium MRI is the preferred imaging modality, with contrast-enhanced power Doppler ultrasound emerging as a new technique for lesion differentiation.

    Conclusions:

    • Liver transplantation remains the optimal long-term treatment for HCC.
    • Resection is a viable alternative for select patients without portal hypertension and with preserved liver function.
    • Continued research into gene expression and improved diagnostic tools is crucial for advancing HCC management.